Feline infectious peritonitis, commonly known as FIP, is one of the most stressful diseases a cat owner may face. In addition to worrying about the cat’s health, treatment cost is also an important factor that many owners need to consider.

Today, GS-441524 has become one of the most discussed antiviral compounds in the FIP treatment field. However, the total cost of FIP treatment can vary widely depending on the cat’s weight, type of FIP, medication source, tablet strength, treatment duration, veterinary monitoring, and whether the product has clear registration information and batch traceability.

For cat owners, comparing FIP treatment cost should not be based only on “how much one box costs.” It is also important to compare the strength per tablet, total amount per box, cost per mg, product source, verification support, and customer guidance.

Main Factors That Affect FIP Treatment Cost

The cost of FIP treatment is not only the price of the medication itself. Several factors can affect the total cost:

Cat’s body weight
Heavier cats usually require a larger total amount of medication, which increases the overall cost.

Type of FIP
Wet FIP, dry FIP, ocular FIP, and neurological FIP may require different treatment planning. Ocular and neurological cases often require more careful monitoring and higher-intensity treatment plans.

Medication strength
For example, 30 mg tablets, 50 mg tablets, injectable concentrations, or oral liquid concentrations can all affect cost calculations.

Treatment duration
Many FIP treatment plans are discussed around an 84-day course, but the actual plan should depend on the cat’s response, body weight changes, bloodwork, and professional assessment.

Veterinary checkups and monitoring
CBC, chemistry panels, albumin/globulin ratio, bilirubin, imaging, follow-up visits, and supportive care may all add to the total cost.

Product source and traceability
Products with registration information, batch numbers, verification systems, and customer guidance may provide more confidence than unclear-source products.

Is GS-441524 FDA Approved in the United States?

In the United States, GS-441524 is not currently FDA approved as a veterinary drug for treating FIP in cats. The FDA has stated that animal drugs compounded from bulk drug substances are unapproved drugs, but under certain guidance conditions, the agency has described situations where it generally does not intend to take enforcement action for certain compounded animal products.

This means that compounded GS-441524 may be available in the U.S. through veterinary prescription and compounding pharmacy channels, but compounded availability is not the same as FDA approval.

At the same time, regulatory status differs from country to country. NeoFipronis® is positioned as the world’s first GS-441524 product approved for the treatment of feline infectious peritonitis, and it has been officially registered in Laos as an oral GS-441524 tablet product for cats.

This does not mean NeoFipronis® is FDA approved in the United States. Instead, it shows that GS-441524 has entered an official veterinary registration pathway outside the U.S.

Current GS-441524 Price Comparison

Public pricing shows that different GS-441524 products can vary significantly in cost. When comparing prices, cat owners should look not only at the box price, but also at strength per tablet, total amount per box, approximate price per tablet, and approximate cost per mg.

Stokes Pharmacy publicly lists Bova GS-441524 50 mg pricing as: 10 tablets or 10 mL for $195, 20 tablets or 20 mL for $325, and 40 tablets or 40 mL for $546.

From the comparison above, NeoFipronis® is priced at $168 per box, with 30 tablets per box and 30 mg per tablet, providing a total of 900 mg GS-441524 per box. Based on cost per mg, NeoFipronis® is approximately $0.19/mg, lower than the publicly listed Bova GS-441524 tablet options above.

Why Box Price Alone Can Be Misleading

Some products may have different box prices, but their strength, tablet count, and total GS-441524 content may also be different.

NeoFipronis®:
30 mg × 30 tablets = 900 mg total per box, priced at $168.

Bova GS-441524 via Stokes, 10-tablet pack:
50 mg × 10 tablets = 500 mg total per box, priced at $195.

Therefore, when comparing FIP treatment cost, cat owners should not only ask “how much is one box?” They should also check:

How many mg per tablet?
How many total mg per box?
What is the actual cost per mg?
Is there official registration information?
Does the product support batch traceability and verification?
Is reliable customer guidance available?

From a practical cost perspective, cost per mg is often more useful than box price alone.

Comparison of Other FIP-Related Treatment Products

Current FIP-related products that cat owners may encounter include GS-441524 tablets or injections, compounded GS-441524 in the U.S., GC376, molnupiravir-related products, and unclear-source black-market products. These products differ in price, availability, regulatory status, and ease of use.

From a pricing transparency perspective, NeoFipronis® has a clearer structure: $168 per box, 30 tablets per box, 30 mg per tablet, and 900 mg total GS-441524 per box. This makes it easier for cat owners to estimate cost based on body weight and treatment duration.

Estimated NeoFipronis® Cost by Cat Weight

Actual cost depends on body weight, daily amount, treatment duration, type of FIP, and professional guidance. The example below is for cost estimation only and should not replace veterinary advice.

Using an example calculation of 15 mg/kg/day for 84 days:

For ocular or neurological FIP, the total amount needed may be higher. Cat owners should confirm the treatment plan with a veterinarian or experienced professional support team.

Why Black-Market FIP Drugs Are Not Recommended

In the history of FIP treatment, black-market GS-441524 products were once common. Many cat owners, desperate to help their cats quickly, purchased so-called “441” products through informal channels, chat groups, private sellers, or unclear-source websites.

However, from the perspective of safety, transparency, and long-term treatment planning, black-market FIP drugs are not recommended.

Main concerns include:

Unclear ingredient and strength
Black-market products may only be labeled as “441” or “GS,” without clearly stating the active ingredient, strength per tablet, concentration, or actual specification. Cat owners may not be able to confirm whether the product contains enough GS-441524.

No official registration information
Unclear-source products usually cannot provide clear veterinary registration information or explain under which country or regulatory system the product is recognized.

Lack of batch traceability
A more transparent product should have a batch number, production information, expiry date, and traceability method. Black-market products often lack complete batch records, making it difficult to trace the source if problems occur.

No reliable verification method
Many black-market products have no official website, verification system, or authorized channel. Cat owners cannot easily confirm whether the product is authentic, substituted, diluted, or counterfeit.

Uncertain quality consistency
Drug quality depends not only on the active ingredient, but also on manufacturing conditions, raw material quality, tablet production process, storage, and transportation. Black-market products may lack stable quality control.

Limited after-sales support
FIP treatment often requires ongoing monitoring of weight, appetite, energy level, bloodwork, and clinical response. Black-market sellers may only focus on sales and may not provide continued product information, usage communication, or support.

Exaggerated claims
Some black-market products may claim “guaranteed cure,” “no relapse,” “no vet needed,” or “suitable for all FIP types.” FIP is a complex disease, and every cat is different. Any absolute claim should be treated with caution.

Why Product Transparency Matters More Than Low Price

FIP treatment is usually not a one-time purchase. It is a process that may last weeks or longer. Cat owners need more than just medication. They also need clear product information, stable supply, batch traceability, verification support, and responsible guidance.

When choosing a GS-441524 product, cat owners should check:

Is the product name clear?
Is GS-441524 clearly listed as the active ingredient?
Is the strength per tablet or per mL clearly stated?
Is there a batch number and expiry date?
Does the product support verification?
Is there official registration information?
Is customer guidance available?
Does the seller explain FDA status and country-specific regulatory status honestly?

A lower price does not always mean better value. If the product source is unclear, the strength is not transparent, or the product cannot be traced, the risk may be higher.

NeoFipronis® vs. Black-Market Products

NeoFipronis® is an oral GS-441524 tablet product for cats. Each tablet contains 30 mg GS-441524, also known as Pronidesivir.

Compared with unclear-source products, NeoFipronis® focuses on:

Official registration in Laos
Clear 30 mg tablet strength
30 tablets per box, priced at $168
Product verification support
Batch traceability support
Customer guidance
Clearer product identity

For cat owners, FIP treatment should not be about choosing only “the cheapest option.” It should be about choosing a product with clearer information, a more transparent source, traceable batches, and more reliable support.

Other Costs Cat Owners Should Consider

Medication is only one part of total FIP treatment cost. Cat owners may also need to budget for:

Initial veterinary examination
CBC and chemistry panels
Ultrasound or imaging if needed
Follow-up visits
Supportive medications
Nutritional support
Emergency care in severe cases

Because every FIP case is different, the final total cost may vary from cat to cat.

Final Thoughts

FIP treatment cost in cats depends on the cat’s weight, type of FIP, medication choice, treatment duration, veterinary monitoring, and product source.

In the United States, GS-441524 is not currently FDA approved as a veterinary drug for FIP in cats, although compounded GS-441524 may be available through veterinary prescription channels under specific conditions. Compounded availability is not the same as FDA approval.

At the same time, GS-441524 has entered an official veterinary registration pathway outside the U.S. NeoFipronis® is positioned as the world’s first GS-441524 product approved for the treatment of feline infectious peritonitis and has been officially registered in Laos.

NeoFipronis® has a clear pricing structure: $168 per box, 30 tablets per box, and 30 mg per tablet. Compared with unclear-source or unverifiable black-market products, NeoFipronis® provides a more transparent oral GS-441524 tablet option with product verification, batch traceability, and customer guidance.